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The intergeniculate leaflet (IGL) of the thalamus is an important neuronal element of the
mammalian circadian time-keeping system. It receives direct input from retinal ganglion
cells. In addition, there are, among other projections, afferents to the IGL from the brainstem
cholinergic nuclei. The aim of the present study was to determine the influence of intravenous
(i.v.) application of atropine  a muscarinic acetylcholine receptor antagonist, on the
ultra-slow isoperiodic oscillations of the IGL neurons. Spontaneous neuronal activity was
extracellularly recorded from the rat IGL. Different concentrations of atropine were
administrated after recording baseline activity. In all experiments, the period of oscillation
became longer after injection of atropine. In some of cases we also noted a temporary
disturbance of the oscillatory pattern of neuronal activity. These data suggest that the
oscillatory firing of IGL cells can be modulated by cholinergic influence.
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In mammals, the circadian time-keeping system
(CTS) is established by two major neuronal struc-
tures: the suprachiasmatic nuclei (SCN) of the an-
terior hypothalamus and the intergeniculate leaflet
(IGL), a distinctive subdivision of the lateral geni-
culate nucleus (LGN) of the thalamus (MOGA &
MOORE 1997; MOORE et al. 2002). Light is a prin-
cipal zeitgeber that synchronizes circadian
rhythms to the environmental light-dark (LD) cy-
cle. Both mentioned structures receive direct input
from retinal ganglion cells. Additionally, the IGL
receives non-photic information and is responsible
for the integration of this information with photic
effects transmitted by the optic tract (WEBER &
REA 1997). The main neuronal pathways convey-
ing non-photic information arrive from the origin
of non-specific projection localized in the brain
stem. Several anatomical, pharmacological and
electrophysiological studies confirm the existence
of such afferents to the intergeniculate leaflet from
locus coeruleus (LC), dorsal raphe nuclei (DRN)
(BLASIAK et al. 2006; MOORE & CARD 1994) or
brainstem cholinergic nuclei – mesopontine
laterodorsal tegmental (LDTg) and pedunculpon-
tine tegmental nuclei (PPTg) (BRAUER et al. 1984;
HOROWITZ et al. 2004; LEVEY et al. 1987;
PEKALA et al. 2007).
Considerable data support a role of cholinergic
agents as regulators of the circadian system. Elec-
trophysiological studies have shown that SCN
neurons are responsive to the iontophoretical ap-
plication of acetylcholine (ACh), both in vivo and
in vitro (KOW & PFAFF 1984). Also carbachol – an
agonist of the cholinergic receptors, has been
shown to shift the phase of circadian rhythms in ro-
dents when administered intraventricularly or di-
rectly into the suprachiasmatic nucleus (BINA &
RUSAK 1996; LIU & GILLETTE 1996). Moreover,
nicotine administration induces c-Fos-like immu-
noreactivity in the SCN in a time- and dose-
dependent manner (FERGUSON et al. 1999).
Despite the well-studied role of acetylcholine in
the circadian system, little is known about the
functional significance of the connection between
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brainstem reticular formation and the IGL. Experi-
ments with potentials evoked in the intergenicu-
late leaflet (by stimulating the contralateral SCN)
and inhibition after LDTg stimulation (LEWAN-
DOWSKI & BLASIAK 1999) suggest that the activ-
ity of the IGL can be influenced by the cholinergic
projection from LDTg. Moreover, recent results
obtained by our group indicate the modulatory ef-
fect of carbachol on the glutamate-induced activ-
ity of the IGL neurons (PEKALA et al. 2007).
In previous studies, we have demonstrated the
existence of isoperiodic ultradian oscillations in
the neuronal firing of the rat IGL (LEWANDOWSKI
et al. 1999) which are suggested as a basic activity
of this structure as well as the whole neuronal
mechanism of CTS (LEWANDOWSKI & BLASIAK
2004). However, the cholinergic influence on this
rhythmic bursting is unknown.
Therefore, the aim of the present study was to de-
termine whether and how the intravenous injection
of atropine – the antagonist of muscarinic cho-
linergic receptors, affects the rhythmic oscillation
in the activity of intergeniculate leaflet neurons.
Material and Methods
The experiments were successfully performed
on 10 male Wistar rats weighing 300-400 g, kept
on a 12:12 light-dark cycle (light on at 08:00 h),
bred in our laboratory. Water and food were avail-
able ad libitum. All the animal handling and surgi-
cal procedures were carried out in accordance with
the European Community Council Directive of 24
November 1986 (86/609/EEC) and Polish national
law. The animals were anesthetized with intraperi-
toneal injection of Urethane (1.5 g/kg, dissolved in
2 ml of saline, supplemented later if necessary;
SIGMA). The femoral vein was then catheterized
for intravenous drug administration and the ani-
mals were mounted in a stereotaxic apparatus
(ASI). During the experiment, the animal’s body
temperature was monitored and maintained ther-
mostatically at 37±0.5°C. A sagittal incision was
made and the upper surface of the skull was ex-
posed and cleaned. After exposing the skull sur-
face, the incisor bar was adjusted until the levels of
lambda and bregma were equal. Craniotomies
were performed above the level of the IGL and vis-
ual areas of the cortex to permit microelectrode
penetration into the IGL and implantation of an
EEG recording electrode. EKG and EEG signals
were monitored to verify the physiological state of
the animals.
The extracellular recording of neuronal activity
within the IGL (stereotaxic coordinates: AP: -4.5
mm, LM: 3.9 mm, DV: 4.5-5.0 mm from the
bregma) was performed using glass microelec-
trodes (impedance 5 Mohm) filled with 2 M NaCl
and 2% Chicago Sky Blue. An EEG signal from
the visual cortex was epidurally recorded with a
silver ball electrode. The recording was carried out
under constant illumination (300 lux at the ani-
mal’s eye level). The signal from the electrodes
was amplified (10 000× for MUA; 5000× for
EEG), filtered (0.3-3 kHz for MUA; 1-200 Hz for
EEG) using an Axon Instruments CyberAmp 380,
and sampled by Micro 1401 mk II (CED) equip-
ment and software (Spike2) for storage and further
analysis.
In each experiment, after achieving baseline ac-
tivity, Ringer solution (vehicle for atropine) was
administrated intravenously. After another 20
minutes of recording, atropine (ATR, Sigma) in a
dose of 4 or 8 mg/kg (4% or 8% concentration re-
spectively), diluted in the Ringer solution, was in-
fused intravenously. Only one infusion of the
control solution and one of the drug was performed
on the same animal.
At the end of the experiment, a current of -5 FA
was passed through the recording electrode for 3.5
min in order to mark the exact position of the tip of
the electrode.
During the experiment, rate-meter histograms of
IGL neuronal activity (1-s bins) were generated.
To determine the period of rhythmic bursting ob-
served in the IGL, Fast Fourier Transforms were
applied to 1200-s intervals in the rate-meter histo-
grams before vehicle infusion, and directly before
and immediately after drug application.
All values were tested for a normal distribution
using Shapiro-Wilk’s W test (normality was as-
sumed for W significance of P>0.05). The changes
induced by drug application were analyzed by a
one-way repeated-measure ANOVA. Statistical
significance was judged at P<0.05.
All the descriptive statistical data are given as
means ±S.E.M. Statistical calculations including
Fast Fourier Transforms, autocorrelation function
analysis and generation of the histograms of firing
frequency distribution were made using Statistica
software (StatSoft).
Results
After recording the baseline of slow bursting
neuronal activity in the IGL (at least 20 min),
Ringer solution was intravenously injected into
the femoral vein. As the administration of the vehi-
cle alone caused no changes in the pattern of neu-
ronal activity (P=0.995, F=0.00004) (Figs 1, 3),
after another 20 min of recording, the muscarinic
cholinergic receptor antagonist – atropine, was ap-
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Fig. 1. Firing rate histogram showing rhythmic, slow bursting activity of IGL neurons. Vertical bars indicate the time of i.v.
injection of vehicle and atropine. Bin size =1 s.
Fig. 2. (Top) Firing rate histogram of the IGL neuronal activity before and after drug application (vertical bar). Bin size = 1 s.
Horizontal, hollow bars indicate intervals for which the distribution of firing frequencies and the autocorrelation functions
were estimated. (Bottom) A, C, E – histograms showing the distribution of the firing frequencies of IGL neurons before (A)
and after (C, E) drug application. Bin size = 2Hz. B, D, F – curves of the autocorrelation function of IGL neuronal activity
before (B) and after (D, F) injection of atropine.
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plied. In all experiments, after atropine injection,
the period of observed oscillation became longer
(P=0.0005, F=31.27) (Figs 1, 2, 3). In 5 cases, im-
mediately after drug injection, a temporary disap-
pearance (no more than 600 s) of rhythmic slow
bursting activity was observed (Fig. 2). During
this period, neuronal firing was characterized by a
flat curve of the autocorrelation function and by an
unimodal distribution of frequencies in the firing
rate histogram (Fig. 2C, D). After this transient
disturbance a recovery of the slow bursting activ-
ity was observed, but the period of neuronal oscil-
lation, as in the remaining cases, was significantly
longer than before drug application (Figs 1, 2E, F,
3A). After drug application, recording was carried
out in a few cases even up to 5 hours and no recov-
ery to the previous period’s length was observed.
The period’s broadening did not differ statisti-
cally between the two applied doses (P=0.29,
F=1.26). However, after injection of ATR in a
dose of 8 mg/kg, the increase of the mean period of
the observed oscillation was smaller (Fig. 3B).
The injection of atropine had no statistically sig-
nificant effect on the mean firing rate (P=0.45,
F=0.63).
Discussion
In the present study, we have clearly demon-
strated that intravenous injection of a general mus-
carinic receptor antagonist – atropine – alters the
neuronal firing of the oscillating cells within the
rat IGL. In all investigated cases, the blockade of
muscarinic receptors caused an enlargement of re-
corded ultradian oscillations. In addition, in half of
the cases, we observed temporary disturbances of
the rhythmic pattern of neuronal activity. Interest-
ingly similar effects on the neuronal oscillations
were previously observed after blockade of GABAA
receptors by bicuculline (BLASIAK & LEWAN-
DOWSKI 2004).
A significant limitation of the present study is
that general administration of atropine does not de-
termine the precise site of the action of the drug.
Therefore, in our discussion we can only suggest
the probable locus of atropine effect.
The work by MOORE and SPEH (1993) has dem-
onstrated that virtually all IGL neurons are
GABA-ergic and that GABA is colocalized with
enkephalin in the population of neurons projecting
to the contralateral IGL, and with neuropeptide Y
in the population of neurons projecting to the SCN.
They showed also that most of the SCN cells are
GABA-producing and proposed to consider
GABA as the principal neurotransmitter of the cir-
cadian system. On the basis of this anatomical
study we can consider the action of atropine on
GABAergic neurons.
Central mAChRs are most frequently found at
presynaptic sites and their activation leads to the
modulation of neurotransmitter release. They have
been known to regulate GABAergic transmission
with diverse effects: acetylcholine, as well as mus-
carinic receptor agonists, can either enhance or
suppress GABA release. There are some data indi-
cating that activation of mAChRs stimulates the
release of GABA in rat substantia nigra, globus
pallidus or neostriatum (HARSING Jr & ZIGMOND
1998; KAYADJANIAN et al. 1994; KAYADJANIAN
et al. 1997). However, in rat cortex, corpus stria-
tum or midbrain dopaminergic neurons (GRILLNER
et al. 2000; HASHIMOTO et al. 1994; MARCHI et al.
1990) it is able to inhibit GABAergic synaptic
transmission and GABA release. It is interesting to
note that these opposing effects were antagonized
by atropine. The nature of the response was de-
pendent, first of all, on the receptor subtypes in-
volved, but there were also essential discrepancies
between different brain regions and effective
doses of muscarinic drugs required to obtain
modulatory effects.
There is much data demonstrating the distribu-
tion of mAChRs and showing the action of the
cholinergic agents in many regions of CNS.
PLUMMER et al. (1999) have identified specific
muscarinic receptors for acetylcholine in the rat
LGN, although they do not distinguish IGL from
Fig. 3. Bar graph showing the mean periods of neuronal
oscillation within the IGL. A – vertically dashed bar
indicates the mean period before vehicle injection
(baseline); solid bar – the mean period after vehicle
injection (control); hollow bar – the mean period after drug
injection. B – solid bar indicates the mean period after
atropine injection in a dose of 4 mg/kg; hollow bar – the
mean period after an injection in a dose of 8 mg/kg. Asterisk
shows statistically significant difference. Each bar shows
the mean period ± S.E.M.
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the lateral geniculate complex. They have revealed
especially dense immunoreactivity in the entire
LGN for a m2 receptor subtype known as an auto-
receptor or heteroreceptor, regulating the release
of neurotransmitters. Additionally, they have
demonstrated that neurons immunopositive for the
m2 receptor have a somatodendritic morphology
of internurons. Because IGL cells involved in the
observed oscillations form an interconnected net-
work of GABAergic interneurons (similar to that
formed by GABAergic cells in the SCN) (BLASIAK
& LEWANDOWSKI 2004), it can be presumed that
the m2 receptor may be the predominant muscar-
inic receptor subtype associated with these inhibi-
tory neurons in the IGL, as in the LGN and the
entire thalamus. Furthermore, there are numerous
studies describing the suppressed effect of cho-
linergic modulation on the inhibitory action of in-
terneurons (MCCORMICK & PAPE 1988; MCCORMICK
1992). Therefore, we suggest that the application
of atropine, by acting on the m2 receptor subtype,
could have decreased the release of GABA and
consequently suppressed the action of this neuro-
transmitter on the IGL bursting cells, thus induc-
ing the longer action of neuronal firing. This kind
of atropine action might be therefore consistent
with the similar effect of bicuculline on IGL oscil-
lations, suggesting a close relationship between
the cholinergic and the GABAergic system within
this nucleus.
Acetylcholine acting on muscarinic receptors
also modulates other types of neurotransmission,
such as dopaminergic or glutaminergic (FORSTER
& BLAHA 2003). Activation of the mAChRs lo-
cated on glutaminergic axon terminals in rat hip-
pocampus can inhibit the release of glutamate (Glu)
and this effect is blocked by atropine (MARCHI et al.
1989). There is anatomical evidence showing the
localization of GluRs mRNAs in the rat IGL
(SATO et al. 1993). Electrophysiological data from
our laboratory (BLASIAK et al. 2007; PEKALA et
al. 2007) has shown responsiveness of the IGL
cells to Glu, therefore confirming the existence of
Glu innervation of the IGL. For this reason, an-
other possible locus for atropine effects is a block-
ade of mAChRs located on glutamatergic nerve
terminals and excitation of Glu release.
Because of the systemic injection of the drug, we
could not exclude affecting the muscarinic recep-
tors of neurons in other brain regions. It is possible
that the observed effect is due to the blockade of
mAChRs in the structures that simultaneously re-
ceive cholinergic innervations and whose neurons
project to the IGL. What is even more probable, the
observed amplification of the oscillations in extra-
cellular activity of the IGL cells could be a conse-
quence of altered neuronal activity of afferent struc-
tures and direct action of atropine on the IGL cells.
In half of the cases, immediately after injection
of atropine, we noticed transient disturbances in
the rhythmic neuronal activity. This effect was
neither dependent on the applied dose of the drug
nor on the circadian time of injection. Interest-
ingly, this disappearance of rhythmic slow burst-
ing in IGL activity appears after intracerebro-
ventricular infusion of bicuculline or picrotoxin
and also after a shift from dark to light (BLASIAK
& LEWANDOWSKI 2004; LEWANDOWSKI et al.
2000). An injection of atropine can enhance ACh
release by blockading ACh autoreceptors in mes-
encephalic reticular formation (MRF) and on the
axon terminals (BAGHDOYAN et al. 1998; MOOR
et al. 1995; ROTH et al. 1996). Therefore, it could
increase the action of ACh on nicotinic receptors,
as their activation requires higher concentrations
of ACh than do muscarinic receptors (LEWAN-
DOWSKI et al. 1993). Activation of MRF (due to an
atropine injection or a light pulse) has been known
to trigger a state of arousal accompanied by desyn-
chronization of EEG. Perhaps this temporary tonic
firing mode of IGL neurons is the time required to
stabilize the modulatory action of ACh released from
MRF cells. The fact that it appears only in 50% of
our experiments could be dependent on the physio-
logical state of an animal. However, this assump-
tion should be tested in successive experiments.
The present results suggest that the oscillatory
firing of IGL cells can be modulated by choliner-
gic influences. However, to fully answer the ques-
tion concerning localization of the site of action of
the cholinergic drug and to define which particular
receptor subtypes are involved in the observed ef-
fect, experiments with local drug application of
agents selective for particular ACh receptor sub-
types are required.
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